NCT04146740

Brief Summary

Rehabilitation in the field of Obstetrics is an emerging field worldwide although it is still very much neglected in a country like Pakistan. Increasing prevalence of GDM has highlighted the importance of rehabilitation in this specific area. In USA upto14% of pregnancies get GDM problem, 6.8 to 10.4 % in China while in India 27.5% which is exceptionally high. Similarly in Pakistan it has become a common issue. Many observational studies have been done to find the risk factors and causes of GDM. However to the best of investigator's knowledge no experimental study have been done so far on the effects of exercise on physical, physiological and psychological aspects of GDM. Hence a randomized control trial is planned on diagnosed GDM patients in Fauji Foundation Hospital Rawalpindi who will recieve supervised structured exercise regeme for 5 weeks and their data will be recorded using reliable tools at the baseline and after 5 weeks to assess the effects of exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 31, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2020

Completed
Last Updated

August 31, 2020

Status Verified

August 1, 2020

Enrollment Period

1.5 years

First QC Date

August 26, 2019

Last Update Submit

August 28, 2020

Conditions

Keywords

exercisepregnancy

Outcome Measures

Primary Outcomes (8)

  • HbA1c

    HbA1c will be assessed at the base line and at the end of 5 weeks session. Lower score shows better outcome.

    5 weeks

  • Blood Pressure

    Change in the Values of Blood pressure will be assessed at base line and at the end of 5 weeks session.

    5 weeks

  • Lipid profile

    Lipid profile will be assessed at the base line and at the end of 5 weeks session

    5 weeks

  • Renal function test (RFT)

    RFT will be assessed at the base line and at the end of 5 weeks session. Lower score shows better outcome.

    5 weeks

  • C reactive protein

    C reactive protein will be assessed at the base line and at the end of 5 weeks session. Lower score shows better outcome.

    5 weeks

  • Heart rate

    Change in the heart rate will be assessed at base line and at the end of 5 weeks session.

    5 weeks

  • Respiratory rate

    Change in the respiratory rate will be assessed at base line and at the end of 5 weeks.

    5 weeks

  • Blood glucose level

    Change in the blood glucose level will be assessed at base line and at the end of 5 weeks session.

    5 weeks

Secondary Outcomes (2)

  • Gestational weight gain

    5 weeks

  • Edinburgh Post Natal Depression scale (Punjabi version)

    5 weeks

Study Arms (2)

Structured Exercise Group

EXPERIMENTAL

Structured Exercise Group will receive medical and dietary interventions like insulin plus structured aerobic exercise regime of moderate intensity by using stationary cycle (3-5 MET) 10 min, brisk walk 10 min The combination of Stabilization exercise (10 repetitions) and PFM training ( 20 repetitions set). Relaxation therapy including Mitchells physiological relaxation technique (10 repeatitions) alongwith deep breathing exercises. Life style modification with postural guidance and back care would also be followed. Exercise dosage would be twice a week for 05 weeks while exercise duration will be 45 to 50 min session under Physio supervision and home plan of 10 min exercise daily. Total 150 min per week. Data will be recorded at baseline then after treatment of 5 weeks.

Other: Structured Exercise for Experimental (Structured Exercise) GroupBehavioral: Control treatment for both groups

Control Group

ACTIVE COMPARATOR

Control Group will receive no structured exercise regime only the group will be receiving medical and dietary interventions like insulin in addition of the postural education and back care from Physical Therapist due to ethical concerns and their outcomes will be observed at the baseline and then after 05 weeks.

Behavioral: Control treatment for both groups

Interventions

Structured aerobic exercise regime of moderate intensity by using stationary cycle (3-5 MET) 10 min, brisk walk 10 min. The combination of Stabilization exercise (10 repeatitions) and PFM training ( 20 repeatitions set). Relaxation therapy including Mitchells physiological relaxation technique (10 repetitions) along with deep breathing exercises.

Structured Exercise Group

Medical and dietary interventions like insulin in addition of the postural education and back care from Physical Therapist.

Control GroupStructured Exercise Group

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales only.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women with age of 20 to 40 years and gestational age more than 20 weeks.
  • Diagnosed Gestational diabetes mellitus patients
  • Must be able to do 6 min walk test and lie under severity level 6 on the 0-10 Borg scale of breathlessness -

You may not qualify if:

  • \. Diagnosed neurological and cardiopulmonary problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University Islamabad

Islamabad, Federal, 45710, Pakistan

Location

Related Publications (5)

  • Aviram A, Guy L, Ashwal E, Hiersch L, Yogev Y, Hadar E. Pregnancy outcome in pregnancies complicated with gestational diabetes mellitus and late preterm birth. Diabetes Res Clin Pract. 2016 Mar;113:198-203. doi: 10.1016/j.diabres.2015.12.018. Epub 2016 Jan 12.

    PMID: 26810272BACKGROUND
  • Wang C, Guelfi KJ, Yang HX. Exercise and its role in gestational diabetes mellitus. Chronic Dis Transl Med. 2016 Dec 20;2(4):208-214. doi: 10.1016/j.cdtm.2016.11.006. eCollection 2016 Dec.

    PMID: 29063044BACKGROUND
  • Bain E, Crane M, Tieu J, Han S, Crowther CA, Middleton P. Diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2015 Apr 12;(4):CD010443. doi: 10.1002/14651858.CD010443.pub2.

    PMID: 25864059BACKGROUND
  • Barquiel B, Herranz L, Hillman N, Burgos MA, Grande C, Tukia KM, Bartha JL, Pallardo LF. HbA1c and Gestational Weight Gain Are Factors that Influence Neonatal Outcome in Mothers with Gestational Diabetes. J Womens Health (Larchmt). 2016 Jun;25(6):579-85. doi: 10.1089/jwh.2015.5432. Epub 2016 Feb 26.

    PMID: 26918922BACKGROUND
  • Brankica K, Valentina VN, Slagjana SK, Sasha JM. Maternal 75-g OGTT glucose levels as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Arch Endocrinol Metab. 2016 Feb;60(1):36-41. doi: 10.1590/2359-3997000000126.

    PMID: 26909480BACKGROUND

MeSH Terms

Conditions

Diabetes, GestationalMotor Activity

Interventions

Population Groups

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

DemographyPopulation Characteristics

Study Officials

  • Wardah Ajaz Qazi, BS-PT, PP-DPT, PhD*

    Foundation University Islamabad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2019

First Posted

October 31, 2019

Study Start

March 12, 2019

Primary Completion

August 27, 2020

Study Completion

August 27, 2020

Last Updated

August 31, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations